Iowa Digestive Disease Center, PC

Clive, Iowa 50325

0 studies enrolling now · 5 studies all time

What they study most

Fibrosis, Inflammatory Bowel Disease, Liver Diseases, Non-alcoholic Steatohepatitis, Nonalcoholic Steatohepatitis, Ulcerative Colitis

Studies at this site

• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis — Completed
• Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study — Completed